Literature DB >> 9827610

DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?

A E Kingsbury1, C D Mardsen, O J Foster.   

Abstract

DNA fragmentation was examined in situ in flash-frozen human postmortem midbrain as a marker for programmed cell death. A large series of cases comprising 16 pathologically confirmed idiopathic Parkinson's disease (IPD) cases, 14 control cases without brain pathology, and a group of 6 patients with other parkinsonian movement disorders were examined using TdT-mediated dUTP-biotin 3' end-labeling histology. Labeling of neurons and glia was seen in the substantia nigra of control and IPD cases and in other movement disorder cases. Labeled nuclei were seen in melanized nigral neurons; apoptotic bodies were also found but were more commonly associated with nigral glia. In the control group, labeling of neurons and glia was strongly associated with poor agonal status, assessed by tissue pH, a marker for antemortem hypoxia. The mean tissue pH of the control group with neuronal labeling was 6.28 (SEM .057), which was significantly different from that of the unlabeled group 6.55 (SEM .055). Mean tissue pH for all cases was 6.38. There was no association of nigral neuronal labeling with poor agonal status in the IPD cases, which showed labeling throughout the range of pH values. However, extranigral labeling, seen in the mesencephalon, red nucleus, superior colliculus, rostral pons, and periaqueductal gray matter, in all three subject groups was associated with tissue pH values of less than 6.3. These findings suggest that DNA fragmentation is influenced by antemortem hypoxia and that apoptosis-like changes seen in the postmortem nigra may parallel those seen in experimental ischemia in the animal brain. The likely influence of perimortem factors on these changes indicates that results from postmortem studies of apoptotic cell death in neurodegenerative disease should be treated with caution and underlines the importance of determining postmortem markers for agonal status in human brain.

Entities:  

Mesh:

Year:  1998        PMID: 9827610     DOI: 10.1002/mds.870130604

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.

Authors:  A Hartmann; S Hunot; P P Michel; M P Muriel; S Vyas; B A Faucheux; A Mouatt-Prigent; H Turmel; A Srinivasan; M Ruberg; G I Evan; Y Agid; E C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs.

Authors:  V Pedersen; W J Schmidt
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

3.  Linking selective vulnerability to cell death mechanisms in Parkinson's disease.

Authors:  Dennis W Dickson
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  Withania somnifera alleviates parkinsonian phenotypes by inhibiting apoptotic pathways in dopaminergic neurons.

Authors:  Jay Prakash; Shikha Chouhan; Satyndra Kumar Yadav; Susan Westfall; Sachchida Nand Rai; Surya Pratap Singh
Journal:  Neurochem Res       Date:  2014-11-18       Impact factor: 3.996

5.  Gene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice.

Authors:  Marina Yamada; Kotaro Kida; Willington Amutuhaire; Fumito Ichinose; Masao Kaneki
Journal:  Biochem Biophys Res Commun       Date:  2010-10-19       Impact factor: 3.575

6.  New evidence on iron, copper accumulation and zinc depletion and its correlation with DNA integrity in aging human brain regions.

Authors:  P Vasudevaraju; Jyothsna T; N M Shamasundar; K Subba Rao; B M Balaraj; Rao Ksj; Sathyanarayana Rao T S
Journal:  Indian J Psychiatry       Date:  2010-04       Impact factor: 1.759

7.  Postmortem studies in Parkinson's disease.

Authors:  Andreas Hartmann
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

8.  Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences.

Authors:  Rebecca Banerjee; Sen Sreetama; Karuppagounder S Saravanan; Sailendra Nath Dey; Kochupurackal P Mohanakumar
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

9.  Alteration of striatal tetrahydrobiopterin in iron-induced unilateral model of Parkinson's disease.

Authors:  Bijay Aryal; Jin-Koo Lee; Hak Rim Kim; Hyung-Gun Kim
Journal:  Korean J Physiol Pharmacol       Date:  2014-04-03       Impact factor: 2.016

Review 10.  Crashing the computer: apoptosis vs. necroptosis in neuroinflammation.

Authors:  Bradlee L Heckmann; Bart Tummers; Douglas R Green
Journal:  Cell Death Differ       Date:  2018-10-19       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.